Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Mostaza

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Revista Clinica Espanola|July 4, 2021
Comprehensive management of risk factors in peripheral vascular disease. Expert consensusV Barrios, P Beato, C Brotons, et al.
Revista Espanola De Cardiologia|September 1, 1996
[Increase of myocardial perfusion during antilipemic treatment in patients with ischemic cardiopathy]J M Mostaza, M del Valle Górnez Martínez, F Gallardo, et al.
Medicina Clinica|September 9, 1989
[Systemic vasculitis as a cause of fever of unknown origin]A Sendino, F J Barbado, J Fernández Martín, et al.
Revista Clinica Espanola|January 26, 2015
Antithrombotic treatment in elderly patients with atrial fibrillationC Suárez Fernández, M Camafort, J M Cepeda Rodrigo, et al.
Journal of the American College of Cardiology|January 15, 2000
Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levelsJ M Mostaza, M V Gomez, F Gallardo, et al.
European Journal of Internal Medicine|September 29, 2017
Baseline functional status as the strongest predictor of in-hospital mortality in elderly patients with non-valvular atrial fibrillation: Results of the NONAVASC registryA Gullón, F Formiga, M Camafort, et al.
Current Medical Research and Opinion|October 3, 2013
Predictive factors of achieving therapeutic goals of hypertriglyceridemiaX Pintó, P Valdivielso, J M Perez de Juan, et al.
Revista Clinica Espanola|January 4, 2011
[Prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs]C Lahoz, J M Mostaza, M T Mantilla, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2010
Atherogenic dyslipidemia in patients with established coronary artery diseaseC Lahoz, J M Mostaza, S Tranche, et al.
Revista Clinica Espanola|May 22, 2019
Sarcopenia, frailty, cognitive impairment and mortality in elderly patients with non-valvular atrial fibrillationM A Requena Calleja, A Arenas Miquélez, J Díez-Manglano, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Revista Clinica Espanola|July 4, 2021
Comprehensive management of risk factors in peripheral vascular disease. Expert consensusV Barrios, P Beato, C Brotons, et al.
Revista Espanola De Cardiologia|September 1, 1996
[Increase of myocardial perfusion during antilipemic treatment in patients with ischemic cardiopathy]J M Mostaza, M del Valle Górnez Martínez, F Gallardo, et al.
Medicina Clinica|September 9, 1989
[Systemic vasculitis as a cause of fever of unknown origin]A Sendino, F J Barbado, J Fernández Martín, et al.
Revista Clinica Espanola|January 26, 2015
Antithrombotic treatment in elderly patients with atrial fibrillationC Suárez Fernández, M Camafort, J M Cepeda Rodrigo, et al.
Journal of the American College of Cardiology|January 15, 2000
Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levelsJ M Mostaza, M V Gomez, F Gallardo, et al.
European Journal of Internal Medicine|September 29, 2017
Baseline functional status as the strongest predictor of in-hospital mortality in elderly patients with non-valvular atrial fibrillation: Results of the NONAVASC registryA Gullón, F Formiga, M Camafort, et al.
Current Medical Research and Opinion|October 3, 2013
Predictive factors of achieving therapeutic goals of hypertriglyceridemiaX Pintó, P Valdivielso, J M Perez de Juan, et al.
Revista Clinica Espanola|January 4, 2011
[Prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs]C Lahoz, J M Mostaza, M T Mantilla, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2010
Atherogenic dyslipidemia in patients with established coronary artery diseaseC Lahoz, J M Mostaza, S Tranche, et al.
Revista Clinica Espanola|May 22, 2019
Sarcopenia, frailty, cognitive impairment and mortality in elderly patients with non-valvular atrial fibrillationM A Requena Calleja, A Arenas Miquélez, J Díez-Manglano, et al.
Pageof 5